Ryan Merkow to Cost-Benefit Analysis
This is a "connection" page, showing publications Ryan Merkow has written about Cost-Benefit Analysis.
Connection Strength
0.109
-
Cost-effectiveness of treatment strategies for pancreatic head adenocarcinoma and potential opportunities for improvement. Ann Surg Oncol. 2012 Nov; 19(12):3659-67.
Score: 0.087
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma. Ann Surg Oncol. 2013 Dec; 20 Suppl 3:S500-8.
Score: 0.022